A081801 (Lung Cancer) - Clinical Trial

¿Cuál es el Propósito de este estudio?

We are doing this study to see if combining immunotherapy with chemotherapy is a better treatment than chemotherapy alone for NSCLC.

¿Cuál es la Condición que se está estudiando?

Cáncer de pulmón de células no pequeñas (CPCNP)

Adults 18 and older who:

Grupo etario

Adultos

If you choose to join this study, you will get a random assignment (fair, equal chance) to 1 of 3 groups:

One group will receive only chemotherapy for 3 months

Another group will receive chemotherapy for 3 months followed by immunotherapy for up to 1 year

A third group will receive chemotherapy and immunotherapy together for 3 months followed by immunotherapy for up to 10 months

Regardless of group assignment, all study participants will:

Get check-ups from your doctor every 3 months for the first 2 years after treatment
Get check-ups from your doctor every 6 months for the 3rd, 4th, and 5th years after treatment
Get a yearly check-up from your doctor for 5 more years once you hit the 5-year mark after treatment

Altogether, you will continue to see your doctor and study team for 10 years after treatment.